: The COVID-19 pandemic and subsequent implementation of non pharmaceutical interventions reduced transmission of Influenza viruses. The WHO has also noticed a drop-in influenza virus cases; however, it hasn't been precisely characterized. The prospect of concurrent influenza and COVID-19 outbreaks is a major concern for public health professionals. Therefore, in this study, we present our limited data on seasonal influenza activity during COVID -19 period (November 2021–October 2022). A retrospective analysis was conducted in 100 positive and 100 negative COVID-19 cases to look for co-infection with Influenza viruses. Influenza screening was performed with multiplex real-time RT-PCR using standardized techniques for Influenza H1N1/H3N2 with Inf-B on archived respiratory samples. A total of 8% Influenza cases were found with coinfection in only 05 cases denoting a drop of influenza infection during this period. Influenza A(H1N1) was the most common influenza virus followed by Influenza B (lineage not determined). The clinical outcomes of co-infections could not be anticipated and may worsen if novel COVID-19 variants continue to appear. The use of community mitigation measures for the COVID-19 pandemic, are likely to be effective in reducing the incidence of seasonal influenza.
No takes yet. Share an insight, caveat, or question.
Pandey et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: